Komori
Governance4559ZERIA PHARMACEUTICAL CO.,LTD.Pharmaceuticals

Report on Corporate Governance 2026/06/26

The Board of Directors consists of 7 directors, including 4 outside directors, and the Audit & Supervisory Board consists of 4 Audit & Supervisory Board Members, including 2 outside members. The report does not describe any changes from the previous report.

Worth reading
63In focus
Scored from 1 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Governance structure

Company with an Audit & Supervisory Board
Number of directors7 in total, including 4 outside directors
Committee1
Compliance Committee and Sustainability Committee (percentage of outside committee members: not disclosed)
Changes this time

Changes from the previous report: Not disclosed

Governance structure
ItemDetails
Corporate Governance StructureCompany with an Audit & Supervisory Board
Number of directors7 in total, including 4 outside directors
CommitteeCompliance Committee and Sustainability Committee (percentage of outside committee members: not disclosed)
Changes this timeChanges from the previous report: Not disclosed
Items this document does not state (4)
Number of independent officersPolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The reason for any changes from the previous report is not provided.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Report on Corporate Governance 2026/06/26 | ZERIA PHARMACEUTICAL CO.,LTD. (4559) timely disclosure | Komori